Thursday, May 6, 2010

Shopping Time In Medical Technology?

The following has been posted on Investopedia:
http://stocks.investopedia.com/stock-analysis/2010/Shopping-Time-In-Medical-Technology-MDT-VOLC-ZOLL-ABMD-THOR0506.aspx.

It is a little strange for me to see ATS Medical get a bid. We banked that company when I was just a junior analyst at Piper and the CEO/founder, Manny, was (and still is) a one-of-a-kind guy. ATSI has always been something of a sad lesson for me; sad in that it proves that the best technology/product doesn't always win and that the company with the better marketing is more likely to win. 

In any event, it's always fun to speculate on who may be next to go out in the space. I hope you enjoy the piece.  


Amidst the paper blizzard of earnings releases, a little deal in the med-tech world took place. Medical device giant Medtronic (NYSE:MDT) announced that it was buying small cardiology company ATS Medical (Nasdaq:ATSI) for about $370 million in cash and assumed debt. The deal will bring some quality heart valve technology to Medtronic and cash to long-suffering shareholders of ATS Medical.


Buy The TechnologyThe ATSI deal is a relatively minor one in the bigger scheme of things, but it does at least highlight one type of deal that could be increasingly attractive - tucking in a small company that has good technology, but has not been able to leverage it effectively. Following this mold, investors should look for companies that have acknowledged quality technology, but for whatever reasons have not been able to deliver the growth that investors want.

You can read the rest at Investopedia: http://stocks.investopedia.com/stock-analysis/2010/Shopping-Time-In-Medical-Technology-MDT-VOLC-ZOLL-ABMD-THOR0506.aspx.

Relief With Bristol-Myers Squibb

The second piece on Investopedia today - http://stocks.investopedia.com/stock-analysis/2010/Relief-With-Bristol-Myers-Squibb-BMY-PFE-SNY-AZN-MJN0506.aspx.

Although I wrote this one last week, it took a little while to get up on the site. Enjoy.


As I look at the earnings report for pharmaceutical giant Bristol-Myers Squibb (NYSE: BMY), I wonder if the rally in the stock is more of an expression of relief than excitement. Like many of its big-cap pharma brethren, there has been more than just one wall of worry to climb for BMY. 

For the rest, please go to: http://stocks.investopedia.com/stock-analysis/2010/Relief-With-Bristol-Myers-Squibb-BMY-PFE-SNY-AZN-MJN0506.aspx.

Three Growth Med-Techs Show Their Cards

The following went up this morning on Investopedia:
http://stocks.investopedia.com/stock-analysis/2010/Three-Growth-Med-Techs-Show-Their-Cards-HOLX-IRIS-VOLC-GE-CPTS-GPRO-BSX-IHI0506.aspx.

As earnings season winds down, a relatively rare trifecta occurred May 3 as three quality growth med-tech stocks reported their earnings. Hologic (Nasdaq: HOLX), IRIS International (Nasdaq: IRIS) and Volcano (Nasdaq: VOLC) all reported earnings with varying degrees of performance. 

For the full article:   http://stocks.investopedia.com/stock-analysis/2010/Three-Growth-Med-Techs-Show-Their-Cards-HOLX-IRIS-VOLC-GE-CPTS-GPRO-BSX-IHI0506.aspx.

Wednesday, May 5, 2010

Putting The Dow In Perspective

I apologize for the slowness of posting this one, but I do not get automated updates when my pieces go up on the FinancialEdge website.

Here is the article:
http://financialedge.investopedia.com/financial-edge/0510/Putting-The-Dow-In-Perspective.aspx


The Dow Jones Industrial Average (DJIA) is inescapable. No matter how middling a news outlet's coverage of business may be, it is a safe bet that the performance of the DJIA or "the Dow" will be offered up as a comment on how the market is doing.

What is often lacking, though, is a sense of context and significance. Without a bit of perspective on just what the Dow is, it's not that useful to talk about moves in the index, particularly when those moves are talked about only as points.


You can read the rest at:
http://financialedge.investopedia.com/financial-edge/0510/Putting-The-Dow-In-Perspective.aspx

My Humble Solution To The Greek Crisis

Please note - this is intended as satire, not a serious proposal, nor a political commentary.

I think I have arrived at an easy way for Greece to get itself out of this criss.

Unfortunately for Greece, its greatest days were long before the advent of the modern world and concepts like "patents", "trademarks", and "copyrights". But why should that stand in the way? There have been more than a few retroactive patents awarded in the past, and we in the United States have seen fit to grant patents for things like genetic sequences -- something that no man created, but rather just happened to be the first to find.

So, why shouldn't Greece be allowed to hold a patent on arguably its greatest invention?

Democracy.

Now, I know, Greek democracy (or rather, Athenian democracy) is very different than what we call democracy today. In fact, I daresay Athenian democracy would be barely recognizable to Americans as democracy. But let us not quibble over the details.

According to the Democracy Index, roughly 50% of the world today lives under democracy (be it perfect or imperfect). That's about 3.4 billion people, folks.

Now, when the U.S. launched military operations against Iraq, one of the stated reasons was to bestow democracy upon the Iraqi people (along with eliminating potential WMDs, getting rid of Hussein, and holding him accountable for various human rights violations and terrorist activities). So far, our operations have cost America about $704 billion dollars.

Iraq has a population of 31.2 million people. So, if we allow for one-third of the motivation being democracy, that gives us a price of $7,500 per person for democracy. And for the purposes of this exercise, we'll just treat this as a one-time payment paid by the current generation forever more.

Now, the Greeks being fair-minded people won't charge us that established "retail" price that the United States has paid. Instead, they'll grant a perpetual license for 10% of that amount - really a rather reasonable amount when you look at patent licensing agreements for novel technology and innovation.

Do the math (10% of $7,500, multiplied over 3.35B people) and you get a sum of $2.5 trillion. That is what the world, collectively, owes Greece for the right to use democracy.

So, given that the total outstanding sovereign debt of Greece is only about $400 billion, maybe the fairest approach is to call the whole thing even.

Please note - this is intended as satire, not a serious proposal, nor a political commentary.

Tuesday, May 4, 2010

No Safe Harbor?

Where do you want to invest today?

Europe? Good luck.

Europe has problems above and beyond Greece - the "green shoots" of recovery there were always scrawnier than over here, and the decision by the ECB to continue to accept Greek bonds as loan collateral means that institution's credibility is, at best, "stretched". With the possibility of banks in France, Germany, and Spain (and perhaps the UK, Italy, and the Netherlands to a lesser extent) are going to be severely hamstrung by troubles in Greece and Spain, growth in Europe could get pretty difficult. As we've learned over here, it's tough for the economy to be healthy if the bank sector is gangrenous.

The U.S.? Maybe.

I think the U.S. economy is in okay shape for now, but I'm one of the weirdos more worried about *deflation* than inflation (yes, I know public debt is onerous, I know government spending is out of control ... but I majored in Japanese back in college, and I've seen how this scenario can go). The market got over-heated and over-optimistic, but I think we at least have a credible hope to grow. For the next 12-18 months, we should be okay. The 3-year, 5-year, and 10-year horizons are scarier, though.

Emerging markets? Nope.

Brazil is raising rates. India is raising rates. China is trying to deflate a property bubble without strangling the economy. So, the three most interesting emerging markets are all trying to tap the brakes on their economies. Sometimes that works out, but more often than not that "tapping" on the brakes ends up sending the stock market temporarily into the windshield. So, now is a GREAT time to find Brazilian, Indian, and Chinese stock ideas, but I wouldn't be aggressively buying into the headwind of these governments trying to cool things down.

So, where does that leave us?
Gold? Not for me, thanks. Other commodities? Not looking so great ... some are looking strong on a short-term trade (coffee, corn, maybe cattle), but it's hard to feel great about copper sliding off (as that's often a precursor of economic conditions on a more global scale).

Bonds? Probably not, especially with the ratings agencies looking stupid (again), and rates seemingly on the rise.

It looks like we're in for one of those unpleasant periods where the predominant investment decisions are how to minimize the damage, as opposed to how to maximize the gains. But this too shall pass.

In the meantime, maybe I need to brush up on some more Turkish and Nordic stocks...

Oh Wait, Things *Aren't* Alright

So, the market sold off significantly today, allegedly due to fears that the aid package wouldn't help Greece. Really? So, yesterday "the Street" thought things would all work out just fine, but then over Cheerios this morning they all realized "oh wait ... we're all doomed".

I actually don't blame the financial media so much for this. They have a job to do, and their foremost job is to provide answers (or something that looks like answers) for the ever-present question "Why did the market go up/down today?" Nobody ever seems to need to explain a flat market ... though I feel like those are the days when we hear about "battles" between bulls and bears over the latest worries and wild hopes.

Look, Greece is bad and it's going to get worse. The "aid" package isn't going to help and will probably do little more than roil the markets and prop up some European banks long enough for them to move that Greek debt off their balance sheets in a way that doesn't totally devastate their earnings and capital ratios in the short-term. Longer term, there's just no realistic chance that this package spares Greece from default.

And that's okay. Default, like bankruptcy, should be the logical consequence of a series of bad mistakes. It's the ultimate expression of "okay, we eff'ed up ... now we need to start over". What is almost always worse, though, is what people, companies, and nations will do to stave off that bankruptcy. When people are desperate, they get dangerous. Suddenly, stupid risks and ridiculous plans seem reasonable, because the ultimate consequence (bankruptcy/default) looks the same to them. So, they flounder around and make a mess of things for everybody else because they see their downside as being limited to that worst case scenario.

As I said before, I'm not *that* worried about Greece. I'm getting hosed on my Societe Generale stock, but then I have been for a while now anyway. And I still hold that stock because I believe the company will ultimately recover and deliver value in excess of its current price. But will Greece crush us? No.

Now, if Greece, Spain, and Portugal go down, we have a bigger risk. But that's another post for another day.

In the meantime, the stock market was overbought anyway, so we have a market in search of an excuse to go down. The Greek problem is a good enough excuse for now, but even if that problem magically went away, another one would suffice.

Keep holding good stocks and hope for the best. It's dangerous to be blindly optimistic, but there's not a lot of profit in pessimism either.

(Disclosure - I own Societe Generale stock. God help me.)

Monday, May 3, 2010

Learn From Apache's Success

Here is a second piece this morning:
http://stocks.investopedia.com/stock-analysis/2010/Learn-From-Apaches-Success-APA-DVN-SU-UPL-XOM0503.aspx

Mid-major energy company Apache (NYSE:APA) is a curious case of collective amnesia in the professional investment world. Even though Apache has more than proven itself as among the best of the best, it seems as though the company is often questioned, doubted and discounted by analysts and investors.

I mean, if you look at stock performance over the last 15 years, Apache is well ahead of rivals like Anadarko (NYSE:APC), Devon (NYSE:DVN) and Canadian Natural (NYSE:CNQ), and trails only Suncor (NYSE:SU) and EOG (NYSE:EOG) among those in its "weight class". Maybe you would think that that sort of record would earn management the benefit of the doubt.

For the rest of the story:

http://stocks.investopedia.com/stock-analysis/2010/Learn-From-Apaches-Success-APA-DVN-SU-UPL-XOM0503.aspx

Becton Dickinson More Interesting Than You Think

Here's today's first piece on Investopedia. This was a stock (BDX) that I really wanted to cover when I was a sell-side analyst this last time around. Oh well ... water under the bridge.

http://stocks.investopedia.com/stock-analysis/2010/Becton-Dickinson-More-Interesting-Than-You-Think-BDX-CPHD-GPRO-LMNX-ABT-MDT-BAX-RHHBY-QGEN0503.aspx

For many years, Becton Dickinson (NYSE:BDX) has been summarily dismissed by a lot of portfolio managers as "too boring". Well, their loss. Although the stock of this diversified health care and biosciences company could not match the pace of health care all-star Medtronic (NYSE:MDT), it stacks up quite well against the likes of Abbott Labs (NYSE:ABT), Baxter (NYSE:BAX) and many other more "exciting" names. Proof, perhaps, that the steak is more satisfying than the sizzle.

A Quiet QuarterThe first quarter of 2010 was pretty much medium, with little to get excited about in either direction. Revenue growth of about 7% was in line with expectations, while the earnings per share (ex-items) were four cents ahead of the average estimate.

To read the full article, please click:
  http://stocks.investopedia.com/stock-analysis/2010/Becton-Dickinson-More-Interesting-Than-You-Think-BDX-CPHD-GPRO-LMNX-ABT-MDT-BAX-RHHBY-QGEN0503.aspx

Buy The Spill?

It's hard not to read the coverage of the oil spill in the Gulf and not start wondering whether some selective vulture capitalism could pay off here.

Everyone involved - BP (BP), Anadarko (APC), Transocean (RIG), Halliburton (HAL), and Cameron (CAM) - has taken a pummeling from the accident. It's difficult to imagine, though, that the damage is ultimately going to be as bad as the declines in the market caps all suggest.

RIG and CAM, in particular, are the names I'm looking at right now. BP is a fine producer and the decline in the stock in the wake of the blowout and rig sinking has certainly put the stock at a point where I think long-term investors will come out nicely. But BP just isn't the type of stock I normally play.

The real question here is a two-parter. First, what will the final sum be for the cleanup costs, legal fees, and settlements? This is a big spill and it was going to be expensive in its own right to clean up. Now with lawyers descending on the Gulf coast like locusts on a corn field, the odds that all involved will be in court for years have to be close to 100%.

The second part is how the expenses get apportioned between the players.

BP has publicly stated that it wasn't their people on the rig or operating the drilling. That's true ... but also irrelevant. Most drilling contracts specifically provide that the leaseholders (BP and Anadarko) are responsible for any accidents unless those accidents can be shown to be the result of "gross negligence" on the part of the driller. So, RIG is going to be on the hook for the rig itself and some related contamination expenses (diesel, etc.). On top of that, the rig was insured for about $560M, and the company carries $950M in third-party liability coverage.

Cameron was the company that made the BOP (blowout preventer), and that piece of equipment is going to get a lot of attention. Generally speaking, a BOP is supposed to prevent exactly what happened on the Deepwater Horizon, but for whatever reason it didn't. I've seen some sources indicate that the BOP was beyond its guaranteed/warrantied life, and it is at least possible that the device wasn't properly tested and maintained. In any case, CAM has a $500M liability policy to deal with cases like this. The bigger risk, though, is that if the BOP is deemed at fault (and badly made), CAM could lose a lot of share to NOV and other rivals.

Last and not least, I wonder about Halliburton. HAL was doing the cementing just prior to the blowout. Did something about that procedure trigger the explosion? In any case, HAL usually has contracts in place that indemnify them or at least limit the liability in cases like this.

All in all, it's a big mess and it's going to take months (if not years) to fully lay out the blame. In the meantime, BP is a pretty cheap stock at these levels. I'd actually prefer Apache (APA) myself, though, as it has taken a few hits along the process of this accident. I have to say I'm very intrigued by Transocean and Cameron at this levels; I've liked both stocks for a long time, but have held off because of valuations. It seems extremely unlikely that either RIG or CAM is going to have a big bill to pay as a result of this accident, and so long as neither company's products or actions are targeted as being the direct cause, the stocks should recover pretty nicely in the long run.

Friday, April 30, 2010

GlaxoSmithKline On Simmer

The last of the run for today (I think...):

http://stocks.investopedia.com/stock-analysis/2010/GlaxoSmithKline-On-Simmer-GSK-LLY-PFE-ABT-NVS0430.aspx

Why Stocks Aren't That Scary

This is my second article for Investopedia's (relatively) new FinancialEdge website:

http://financialedge.investopedia.com/financial-edge/0410/Why-Stocks-Arent-That-Scary.aspx

Reading the news these days, it almost seems like there is something a little wrong with you if you are not afraid of the stock market. We have seen two major stock market declines in less than 10 years. On top of all that is the ever-present fear of losing money.

Still, potential investors should think a little more about the real risks in the stock market. Stocks are not actually that scary, and if people keep a few points in mind, they can successfully navigate the real hazards and be at ease with investing in stocks. (If the unpleasant emotions in When Fear And Greed Take Over are allowed to influence your decision-making, they may cost you dearly.)

For the rest:
http://financialedge.investopedia.com/financial-edge/0410/Why-Stocks-Arent-That-Scary.aspx

Can Boston Scientific Ever Get It Right?

And so continues my long love affair with not liking Boston Scientific (BSX).

http://stocks.investopedia.com/stock-analysis/2010/Can-Boston-Scientific-Ever-Get-It-Right-BSX-STJ-MDT-ABT-VOLC0430.aspx

It is only fair to state that from the beginning that I have been a long-term skeptic and critic of Boston Scientific (NYSE:BSX), going back to the late 1990's when I covered the stock as a junior research analyst. Ever since, my skepticism has been rewarded as the company has made missteps and blunders too numerous to recount here. 

With a relatively new CEO at the helm and earnings fresh on the tape, it's worthwhile to take another look at this well-known name to see if anything has changed for the better.  

For the remainder of the article: 
  http://stocks.investopedia.com/stock-analysis/2010/Can-Boston-Scientific-Ever-Get-It-Right-BSX-STJ-MDT-ABT-VOLC0430.aspx

Plum Creek Gets Pruned

I wrote the following on Plum Creek (PCL), one of my favorite REITs and a stock I wish I had just held on to instead of sold a long time ago...
http://stocks.investopedia.com/stock-analysis/2010/Plum-Creek-Gets-Pruned-PCL-WY-RYN-IP-NP0430.aspx

Memo to Plum Creek Timber (NYSE:PCL) management - in the future, try not to post earnings on the same day that western Europe appears to be melting down into the financial Stone Age. 

That would be the most logical explanation to this writer, as to why the stock is down nearly 8% (as of Tuesday's close), on earnings that were at least acceptable. Still, whenever the stock of a high-quality company goes down more than it should in the absence of truly bad news, I get a little interested.  

For the rest, click on through: 
http://stocks.investopedia.com/stock-analysis/2010/Plum-Creek-Gets-Pruned-PCL-WY-RYN-IP-NP0430.aspx

WellPoint Still On Point

There will be several articles by me going up on Investopedia today (and maybe Monday). Here's the latest.

http://stocks.investopedia.com/stock-analysis/2010/WellPoint-Still-On-Point--WLP-UNH-SNY-GSK-QDEL0430.aspx

The health insurance industry has seen more than its usual share of turbulence over the past year, what with the healthcare reform debate and seemingly mandatory attacks on the health insurance industry. Through all of that, WellPoint (NYSE: WLP) has continued to run its business exceptionally well. 

Results That Get Better As You Go AlongAdmittedly, top line growth is not a preeminent reason to own WellPoint shares. For the first quarter, the company saw revenue drop a fraction of a percent, while operating revenue was down about 3%. The economy is primarily responsible for this; with rising unemployment, the company saw premium revenue drop about 2% on a similar decrease in membership. (For more, see Intro To Insurance: Health Insurance.)


The rest can be read at Investopedia: 


http://stocks.investopedia.com/stock-analysis/2010/WellPoint-Still-On-Point--WLP-UNH-SNY-GSK-QDEL0430.aspx
 

Silicon Labs - Quality Doesn't Come Cheap

The following went up on Investopedia this morning.
Enjoy!
http://stocks.investopedia.com/stock-analysis/2010/Silicon-Labs---Quality-Doesnt-Come-Cheap-SLAB-CSCO-AAPL-ADI-BRCM0430.aspx

The semiconductor business is not for the faint of heart. Lucky for Silicon Labs (Nasdaq: SLAB) shareholders, then, that they have a rather bold and skilled management team. Remember, this is a company that decided about three years ago to sell a profitable wireless business that was about one-third of the company's revenue because management foresaw increasing competition and decreasing profitability. Since that gutsy move, the company has almost completely replaced that revenue despite the recession. 

A Very Strong Quarter In The BooksSilicon Labs reported earnings April 28 that should leave its shareholders satisfied. Revenue rose 51%, while gross margins jumped almost 6%. With significantly higher gross profits, the company was better able to leverage its overhead more effectively even while reporting higher R&D and SG&A expenses. Operating income, then, was significantly higher than in the year-ago period, and the company handily beat estimates.

The rest at: http://stocks.investopedia.com/stock-analysis/2010/Silicon-Labs---Quality-Doesnt-Come-Cheap-SLAB-CSCO-AAPL-ADI-BRCM0430.aspx

Thursday, April 29, 2010

Canadian National Needs To Do More

Here is an analysis of Canadian National (CNI) that I wrote for Investopedia.

I wish I had had the space to go into some of the complaints that have been lodged against CNI by its customers, and the possibility of regulatory involvement in Canada as a result. I don't think it really moves the needle with the company or stock, but it gives a different perspective on how the company conducts itself.


http://stocks.investopedia.com/stock-analysis/2010/Canadian-National-Needs-To-Do-More-CNI-UNP-CSX-GWR-KSU0429.aspx

It is an odd quirk of Wall Street that the best operators in an industry do not always get the most respect from analysts and buy-side fund managers. I think the reasoning is basically that the underperformers have the most room for improvement, and this hoped-for improvement constitutes a "catalyst" in the lexicon of the Street.  

So, in an earnings season where rival rail operators Union Pacific (NYSE: UNP) and CSX (NYSE: CSX) have already reported strong earnings, an "all right" performance from Canadian National (NYSE: CNI) gets a cooler reception. 

For the rest, please click on to:
http://stocks.investopedia.com/stock-analysis/2010/Canadian-National-Needs-To-Do-More-CNI-UNP-CSX-GWR-KSU0429.aspx

Wednesday, April 28, 2010

Can BBVA Be B-B-Believed?

Amidst all the talk of Europe going back to a financial Stone Age, we got to see the earnings from Spain's second largest bank, Banco Bilbao Vizcaya Argentaria (BBVA). In a way, it was something of an anticlimax - no howls of pain, no eye-popping losses, no dire projections or grim predictions of failure. It was an okay report ... maybe almost too okay?

Gross loans were down just slightly from last year, and up a little on a sequential basis. Spain's unemployment is 19%, Portugal's is about 9% (though I've seen a wide range on this stat), and Mexico's is officially about 5 or 6% (but common assumption is that the real rate is much higher). So who, exactly is BBVA lending to? I mean, I realize loans don't disappear just because the economy is bad, but it's just the first oddity that hit me.

Net interest income was up a bit from last year, and down a little on a sequential basis. Deposits were likewise mixed - up a little on a yoy basis, down a little sequentially. Okay, no big deal there. 

Here's where things get really squirrely for me. The non-performing assets ratio was flat from December, at 4.3%, and up from last year's 2.8%. Impairments were up 17% from last year to 1.1B, but down a fair bit from December. Provisioning was up about 8% sequentially (to 9.3B) and up 73% from last year's level. Surprisingly, the company has also been showing really strong recoveries as part of its non-performing assets -- recoveries of 2.4B were booked this quarter, and that was up 20% sequentially and nearly double the year-ago level.

On a net basis, then, the company added 874M euros to NPA, the lowest rate of increase in quite a while; half of December's increase, and a third of last year's. The coverage ratio has gone from 76% in March of 2009 to 59% now.

Now let's just think about this for a moment. With everything we've been seeing in Spain, Portugal, Mexico, and so on, do you really think it makes sense that coverage ratios are decreasing and net provisioning additions should be declining?

BBVA's actions seem to be suggesting that the worst is over ... but the general thought seems to be that trouble has only begun in Spain. What makes this even worse is that Spanish banks used to have a reputation for playing a little fast and loose with numbers - being slow to classify loans as non-performing, extending new loans to bad debtors to allow them to continue making payments on the prior loans, etc, etc.

Now, I happen to like BBVA to a point. I generally like the markets that the company is in, and I think there is good long-term growth potential here. But something about this earnings release just doesn't sit well with me. I hope I'm misinterpreting things or making mountains out of molehills. If I'm right, though, and my suspicions have merit, then BBVA management may be fiddling while their credit burns.

If you have a lot of confidence that Spain and Portugal will somehow walk through the minefield safely, and a faith that BBVA's management is taking a conservative approach to their credit, then this may be a great opportunity to buy while everyone else is panicking.

I, however, don't have that kind of confidence, nor that strong of a stomach. So I'll sit tight for now. I wish BBVA the best and will keep them on the watchlist, but I want to see at least a couple more quarters before I pony up my own cash for these shares.

The Easy Way To An Organized Budget

This article is a little different than my normal work.
Investopedia has developed a site that's more focused on personal finance topics, and I'm writing for this side of the business as well.

So, this won't be the usual buy-sell-hold, but I hope that it's useful all the same.

http://financialedge.investopedia.com/financial-edge/0410/Budget-Smarter-With-Earmarks.aspx

Imagine waking up one day and seeing the sky through a hole in your roof. Or think about what you would do if some knucklehead wrecks your car on the way home from work. Can you write a check without worrying about going into debt or seriously digging into your savings?

We all know that we are supposed to save money for a variety of future needs like emergencies, retirement or big-ticket items. What is not mentioned is how to go about doing this. Creating a budget spreadsheet and earmarking your savings to specific categories is an easy way to make sure you are meeting your savings needs and goals.

The rest at: http://financialedge.investopedia.com/financial-edge/0410/Budget-Smarter-With-Earmarks.aspx

Cummins Comes On Strong

Another piece recently published on Investopedia.
I definitely have a soft spot for industrial tech companies like Cummins ...

(please note: something a little goofy happened to the first paragraph in the editing process. We're working on it...)

http://stocks.investopedia.com/stock-analysis/2010/Cummins-Comes-On-Strong-CMI-TTM-DCI-CAT-ARM0428.aspx

All Clear In Energy Services?

Here is the latest article of mine on Investopedia. I should note that there was a bit of a holdup in the editing process, so this may read as slightly dated. The basic themes in the piece are still very much relevant and timely, though, so I hope you find it interesting.

http://stocks.investopedia.com/stock-analysis/2010/All-Clear-In-Energy-Services-SLB-DO-ESV-HAL-WFT0428.aspx

The last few quarters have not been the easiest for energy services sector, as troubles in Mexico, lower activity in the Gulf, weather difficulties, and project delays have all led to lower demand and lower prices. Still, it was not as though the sector closed up shop, as many U.S. natural gas shale play are economical below the $4 natural gas price level.

On a more positive note, it looks like the operating conditions may be about to turn. The earnings and commentary we have seen from the past week was supportive, and should give fundamentally-inclined investors a bit more evidence that the turn in the business is real. 

For the rest of the article: 
  http://stocks.investopedia.com/stock-analysis/2010/All-Clear-In-Energy-Services-SLB-DO-ESV-HAL-WFT0428.aspx

Tuesday, April 27, 2010

From Sons of Athens ... to Sons of Anarchy




Thanks Greece.

Virtually every financial system is built upon a certain level of trust and good faith amongst its members, and Greece seems to have taken up the role of "turd in the punchbowl". Greece basically lied their way into the European Union, gorged on cheap debt, wasted it on unproductive assets, and then turned around and held the financial system hostage with a version of "bail us out … or else!".

Of course, anybody wasting their time bashing on the Greeks is overlooking events a little closer to home. Let's see … lying to get favorable loans, using those loans foolishly, and then whining, wheedling, and begging for a bailout. Where have we seen that before?

Oh yeah, that's right. We did that too.

Now we have the S&P lowering Greek debt to "junk" (way to be on the stick ahead of time, guys … oh wait, we've seen that before too!), Greek 2-year notes yielding about 19%, and a lot of people nervously watching Portugal, Spain, and Ireland for signs of weakness.

Think about that for a moment … Greek 2-year notes are yielding almost 19%. That's like credit card rates. On second that, maybe I shouldn't have said that … Capital One (COF) may soon be seeing a flood of applications from Athens at this rate.

The scary part, though, is how long this could last. Latvia went into crisis a little while ago and even massive cuts to government wages, pensions, and spending (and other austerity measures) didn't help much. Greece, then, could be looking at quite a few years of high taxes, a sharply contracted public sector, malaise, and discontent. Not too many countries have the capability to withstand that, and there could be unrest as a result (as seen a few years back in Argentina).

It's almost a given that the "market" won't be much help here, and the rescue package will have to come out fully-funded by other European countries. On top of that, you're probably looking at wage cuts of 20% or higher as part of the package, and I don't think many Greek civil servants will be happy about that. Worse still, after 12 or 18 months of that, it may still not be enough and Greece may opt to default/restructure that debt and send more ripples of chaos through the market. Simply put, we're talking here about a program that would take four or five years … and that's assuming that Portugal and Spain don't fall over and make it even worse.

In the meantime, a lot of banks have gotten smacked already. Several German and French banks have (or had) major exposure to Greece, with names like Commerzbank, Credit Agricole, Societe Generale and BNP Paribas among them. The damage there is probably already done, but I'd be very cautious around any banks heavily exposed to Spain … or frankly almost any European country at this point.  After all, plenty of British banks have loans on the books for vacation homes in Spain, so you can never just assume a bank in Country X is safe.

Sooner or later, this storm will pass. The U.S. economic recovery isn't heavily predicated on Europe at this point, though chaos in the credit market can quickly become a global issue. But that isn't to say that the fallout won't cause some chaos and hairy days. Expect talk to begin about creating a mechanism to boot out European Union countries that can't get their stuff together, and should the Euro actually collapse … well, that's probably a really good day to own gold (and probably dollars as well, because as messed up as we are, we're not that bad).

Here's hoping the sons of Athens figure a way out of this mess before it gets too much worse.

(Disclosure - I own shares of Societe Generale)








Monday, April 26, 2010

Viva la FEMSA!

Another one of my companies announced earnings today, this time it was Mexican consumer conglomerate FEMSA (FMX) reporting after the close. Although the results weren't a blowout, they were good enough.

Revenue was up a bit more than 6%, operating income was up almost 10%, and net income was up more than 150% as a lot of "other expenses" weren't repeated. Perhaps just as important for the short-term, the results were basically in line with the analyst estimates.

The company's Coca-Cola business saw revenue up about 5% and operating income up more than 6%, while the beer business saw operating income up almost 13%. Last and certainly not least, the company's Oxxo business posted nearly 29% operating income growth on same-store sales growth of 3%.

I'll be the first to admit that none of those numbers are great for a "growth" stock, but there were at least a few mitigating factors. Mexico's economy is in a rough patch too, particularly in the border regions, and that did no favors for the Coca-Cola and Oxxo businesses. Longer term, though, I still think there's a lot of leverage and potential left in these businesses -- particularly in the Oxxo business, which the company has only now just started to expand outside of Mexico.

Conglomerates pretty much always trade at a discount, and FEMSA is no exception (even if it's not as much of a conglomerate as, say, Nestle (NSRGY) or Pepsi (PEP)). Even with that handicap in place, though, there's an arbitrage opportunity with the Coca-Cola business (it's relatively cheaper to buy FEMSA than Coca Cola FEMSA (KOF)), the Heineken shares that the company is getting in exchange for the beer business, and growth opportunities still ahead with the Oxxo business.

All in all, I'm still quite happy to own FEMSA shares here. Yeah, it's not as exciting as some China stock, but you should be able to get another 20-25% out of this stock before it's trading at parity with its closest comps. That's good for a "Buy" for me.

WRB and ACGL - Two Great Insurance Companies

WRIt was a happy coincidence that two of my favorite insurance companies reported today. W.R. Berkley (WRB) is an exceptionally well-run (if somewhat "quirky") specialty insurance company, while Arch Capital (ACGL) is a player in the reinsurance segment of the market.

I'm not at all surprised to see that WRB posted slightly lower-than-expected revenue, but better-than-expected earnings. WRB is an efficient operator and a very disciplined underwriter -- if the prices aren't up to their standards, the company walks away. When you hear Berkshire Hathaway's (BRK.A) Warren Buffett talk about how most insurance companies lose money on their underwriting, that's why -- they feel like they have to "stay in the game" no matter what the cost. WRB doesn't play that game; if they don't like the terms, they take their money and go home.

So, as a result, gross premiums were down about 2% and net premiums were down about 4%. Operating income was down about 4% as well, though the bottom line result was still about $0.10 better than the average analyst guess. Along the way, book value rose almost 4% from December, and the ROE came in at 13.2%.

Admittedly those don't sound like numbers to do handstands over, but they should be kept in the context of a pretty soft insurance market - rates aren't very good, a lot of companies still have turbulence in their investment portfolios, and analysts aren't too keen on the sector as whole. But that's the point where I get interested in buying -- and I think WRB is an excellent insurance stock to buy in a soft market.

Similar to WRB, Arch Capital posted a beat on earnings and a miss on revenue and it was largely for the same reasons I talked about before; namely, that Arch won't write business that doesn't meet it standards. Right now, that's a problem ... but soft markets have a way of turning into hard markets and Arch Capital will reap the benefits when that turn comes.

Here too, the details don't look spectacular -- gross premiums were down 7%, operating income was down from last year, and the posted ROE of just under 10% isn't all that remarkable. Once again, though, the bottom-line results were better than conservative estimates and this is a company where there can be a lot of operating leverage when pricing firms up.

Arch might be a stock where you want to wait a bit before buying ... namely, until the hurricane season is underway. Major catastrophes like hurricanes are the risk factor for Arch, though experience and history suggests that the company has spread its risks around in such a way that a single major storm (or even several) wouldn't represent a devastating economic loss to the company. Still, by the time the "all clear" has sounded, it may be too late. So investors willing to absorb a little risk might just want to look at these shares now and trust that management's underwriting standards will continue to make this a top idea in the insurance space.

Saturday, April 24, 2010

BB&T - Patience Will Pay Off

I have been pretty outspoken in my appreciation of BB&T (BBT) management and the stock. During the credit crisis, BBT held up a fair bit better than most banking stocks, even though there was a steady drumbeat from analysts worrying about the company's commercial loan portfolio. With this week's earnings, it looks like things are slowly getting better at BBT, though the process of full recovery may take a little longer here than at other banks.

Results for the first quarter were alright. The company beat by $0.04 on an as-reported basis ($0.27 versus $0.23), though reported earnings were about a penny higher than the real earnings. Net charge-offs were 1.84% and the rate of increase has slowed down. For the full year, the company said it expects NCOs to average about 1.8%.

Provisions for the quarter were $575M, about 2.65% (versus 2.55% in December), while gross charge-offs were $509M. Deposits were up about 5% excluding the Colonial deal, while loans were down 4.3%. Some of this loan decline was seasonal, but management did say they were pulling back on deposit growth because they didn't see the loan demand to justify it. Non-interest income was down because of lower gains from securities and lower mortgage banking.

The real debate about BBT is going to center around the credit situation. Past due loans seem to have flattened, and that could be a sign that things have stabilized. I expect some analysts and buy-siders to be worried about the company's big jump in troubled debt restructurings (TDR). These climbed 60% sequentially to $1.7B. The bear case is going to be that the company is being too slow in recognizing loan losses and this is going to slow down the return to "normal" by at least a few quarters.

The company would counter by saying that they applied a separate underwriting process to these TDRs and they didn't restructure any loans that they didn't think would be repaid. So, in short, BBT is relying upon their underwriting standards. Given that the company has done quite well relative to its peers in terms of loan losses and underwriting, I'd be inclined to go along with management on this one. Maybe the TDRs do push out "normal" by a quarter or two, but you haven't made much money over time by betting against BBT management.

Much as I like BBT, and am happy to own the shares, I'm not sure that I'd be pounding the table right now. By my calculations, the stock is about 5 - 10% undervalued, and that's not much of a margin of safety. USBancorp (USB) and Wells Fargo (WFC) both seem relatively cheaper, as does JPMorgan (JPM), PNC (PNC) and a host of smaller, riskier banks. By the same token, BBT rarely ever gets cheap and you could do a lot worse than buy-and-hold this one.

(Disclosure - I own BBT and JPMorgan shares)

Thursday, April 22, 2010

Putting On My Tin Foil Hat

Okay, this is a wild conspiracy, but just hear me out.

The administration wanted to fight against rising medical device and drug prices (and get health care reform passed over industry objections). Suddenly there are antitrust investigations in a couple sectors of the med-tech market (immunohematology, plasma-derived drugs) and rumors of sniffing around for more (hospitals, drug companies, ICDs). The administration has also talked about revoking the antitrust exemptions for the health care insurance industry.

The administration is going after seed companies (specifically Monsanto), is rumored to be looking very carefully at the transport sector, and has publicly warned the petroleum industry that investigations could come.

And now we have the Goldman Sachs suit. Now I don't know whether or not Goldman committed fraud, but having worked on the buy-side in fixed income during the credit crisis, I'm not the least bit surprised that there was self-dealing. I mean, it was basically accepted as fact that some of the brokers were shorting mortgage-backed securities (and related derivatives) while simultaneously creating, packaging, and selling them to investors.

This shouldn't be a big surprise to anybody; these are the same companies that cheerfully banked miserable tech companies in the late 90's, sold them to investors with glowing research reports, and made sure they didn't get caught long on their trading desks because they knew they were crap.

So, anyways, is it fair to wonder whether the Goldman suit is a blunt instrument of policy aimed at telling Wall St. "back off on opposing reform, or we'll nail you and embarrass you even further"? I mean, really, who is going to leap to the defense of those "damn greedy bankers"?

Like I said at the beginning, this is just mostly gonzo conspiratorial theorizing on my part. After all, the Bush administration was uncommonly lax when it came to antitrust investigations and enforcements (in terms of the number of cases pursued compared to past administrations). So maybe we just have aggressive new people in place, and maybe they're making up for lost time and overlooked sins.

Or ... maybe not. Maybe this is how business is going to be done for a few years -- we'll ask you to cooperate, then we'll send a shot across your bow.

Time will tell...

Disclosure - I own shares of Monsanto.

Regional Bank Round-Up

Here's a piece that went up on Investopedia today. It was written a few days ago, so it does not include the major bank earnings that were announced since then.

http://stocks.investopedia.com/stock-analysis/2010/Regional-Bank-Round-Up-USB-ZION-RF-MTB-KRE-WFC-PNC0422.aspx

It seems that banks got us into this mess, but are they finally getting themselves out? If you look at the performance of the stocks, at least as measured by the SPDR KBW Regional Banking ETF (NYSE:KRE), it is tempting to say "yes". After all, regional banks have done well so far this year relative to the S&P 500; up about 25% versus a roughly 7% gain in the broader market index.

If only it were that simple. We have all seen that the market is a measure of what people think is going to happen, and not necessarily an accurate measure of what is happening on the ground. Luckily for all us, a recent batch of big regional bank earnings does suggest that business is looking up.

The rest can be read at:
http://stocks.investopedia.com/stock-analysis/2010/Regional-Bank-Round-Up-USB-ZION-RF-MTB-KRE-WFC-PNC0422.aspx
 

Wednesday, April 21, 2010

First Cash Financial - The Real Pawn Star

Another quarter in the books for First Cash Financial Services (Nasdaq: FCFS), and another reminder to me of why I've held on to this stock for so many years.

Revenue this quarter was up 21% and income from continuing operations was up another 20%. Pawn receivables (which you can think about as something of a preview of future revenue) were up 29%, with over 46% growth in pawn receivables in Mexico. Inventory turns improved pretty significantly, and overall same-store sales were up about 14%.

Mexico has been a big part of this company's growth plans for a while, and that doesn't look to be slowing down. The company opened 14 stores this quarter, and all of those were in Mexico. In fact, about half of this company's revenue comes from Mexico. Given the relatively easier regulatory climate in Mexico, I can't see any good reason for the company to do otherwise -- there's plenty of room to expand in the U.S. (the company operates in just 8 states), but advocacy groups have aggressively targeted payday lending (a small part of FCFS's business) and have periodically gone after pawn operators as well.

Said differently, if you can get nearly 30% revenue growth from Mexico, why bother with the hassles in the U.S.?

Like most companies I own, FCFS continues to generate some pretty prodigious cash flow, and management has been building up cash. Hopefully they're not about to do another dumb deal (buying a buy-here/pay-here auto sales business a couple of years ago was a disaster), and that they'll apply the funds either to share buybacks or further expansion into new markets. Who knows, maybe it's time for them to start investigating Brazil (though there's plenty of room left to grow in Mexico).

This stock has always been relatively volatile and I'm not sure I'd rush to buy today, but I'm not looking to sell any shares and I'm quite content to sit tight as an owner.

(disclosure - I own shares of FCFS)

Tuesday, April 20, 2010

ICU Medical - The Roller Coaster Ride Continues

ICU Medical (ICUI) has always been an unusually volatile stock, mostly due to the company's reliance/relationship with Hospira (HSP). I had hoped that with ICUI's acquisition of HSP's critical care business and the company's expansion of domestic distribution, that volatility would ease up.

Silly wabbit.

ICUI missed on the top and bottom lines, and is taking a spanking in the market today. 

To some extent, this quarter was a "ghost of Hospira" situation, as the critical care business once again under-delivered the goods. Sales were softer than I had been hoping and yet the influence of these sales was still sufficient to lower the gross margin more than I had expected.

On the plus side, the company's core CLAVE business was quite strong, even as the custom tubing business was a little weak. What's more, the company saw great growth in domestic distribution and overseas sales, and Hospira was about 37% of the company's sales. On top of that, the company is apparently making great progress with its plant (under construction) in Slovakia. This plant could be a key catalyst for improving overseas growth; a very under-penetrated market for ICUI.

I still think that this year will be something of a kitchen sink for the company, as management tries to repair the badly neglected critical care business that it bought from Hospira and as the company faces various costs in opening that plant in Slovakia. Longer term, though, I think the company can get a lot of leverage out of both -- critical care is a decent market with only one real competitor (Edwards (EW)) and a little attention and focus here could reap some meaningful cash flow and growth. With the Slovakia plant on line, the company could look to several years of strong (25%+) revenue growth with even better margins and more predictability.

And hey, let's not forget that management basically maintained its guidance -- suggesting that the first half of the year may be a little worse than I'd hoped, but that the second half could be meaningfully better. 

ICUI is a stock that will drive you crazy, but I think you can buy it here and make decent money on it. It's not going to be a go-go grower like Intuitive Surgical (ISRG) or a darling like Illumina (ILMN). What it is, though, is a proven generator of ample cash flow and a management team that does not waste shareholders' time or money.

At this price, I have to admit that I'm thinking of adding it to my own PA.

Monday, April 19, 2010

The Shape of Dry Bulk Shipping

Here is today's Investopedia piece.

http://stocks.investopedia.com/stock-analysis/2010/The-Shape-Of-Dry-Bulk-Shipping-GNK-EXM-DRYS-NM-EGLE0419.aspx

Those huge panamax and capesize freighters may look peaceful as they sail slowly across the oceans, but the stocks behind them are anything but. Betas in the dry bulk space are exceptionally high, with many companies sporting betas above three. Pick the right stock at the right time, and it is easy to see how shipping built the fortunes of many a magnate. Of course, picking the wrong stocks can be like tying your money to an anchor and tossing it over the side. 

You can read the rest at:
http://stocks.investopedia.com/stock-analysis/2010/The-Shape-Of-Dry-Bulk-Shipping-GNK-EXM-DRYS-NM-EGLE0419.aspx

Friday, April 16, 2010

The Delicate Dance of the Banks

So now we have Bank of America's (BAC) earnings in hand as well. Like JPMorgan (JPM), they were better than expected, though not as strong on a relative basis. Like Morgan, BAC saw weak loan growth, good i-banking revenue, and very good trading revenue. There were also continued large reserves taken for the mortgage business.

This is a very delicate little dance we have going on here.

Trading is a fickle business and that revenue could go away fairly quickly; whether from rising interest rates, a federally-imposed restriction on proprietary trading, less volume, or what have you. The recovery in credit cards could also go away quickly if the economy takes another leg down. Last and not least, commercial lending has held up despite everybody's expectation and while that's not as large a business for the JPM/BAC size of bank (relative to the big regional banks), it could mushroom into a big problem.

What it all boils down to for me is this - the easy money in American bank stocks has been made. The economy will get better, bank earnings will improve, and bank stocks have room to go up. But whereas buying bank stocks 18, 12, or even 6 months ago was a decision where you were exploiting excessive fear in the market, that cushion is gone.

On the flip side, the insurance industry hasn't been getting all that much love, but that's a topic for another day...

(disclosure: I own JPMorgan shares)

Thursday, April 15, 2010

Small Med-Tech Names You Should Know

A quirk of timing led to me having two articles posted today on Investopedia.

Here is the second one.


http://stocks.investopedia.com/stock-analysis/2010/Small-Med-Tech-Names-You-Should-Know-ICUI-IRIS-LMNX-HSP-ILMN0415.aspx


Small Med-Tech Names You Should Know

Healthcare is a huge space, and for every Medtronic (NYSE:MDT) or Pfizer (NYSE:PFE), there are dozens of quality names that go unnoticed by the investing public. A little time and effort, though, can uncover some intriguing names that may deserve a place in investors' portfolios. Today we highlight three ideas.

http://stocks.investopedia.com/stock-analysis/2010/Small-Med-Tech-Names-You-Should-Know-ICUI-IRIS-LMNX-HSP-ILMN0415.aspx

If You Can't Beat 'Em, Buy 'Em

Here is today's piece from Investopedia.
http://stocks.investopedia.com/stock-analysis/2010/If-You-Cant-Beat-Em-Buy-Em-XOM-XTO-HAL-RIG-UPL0415.aspx

Interesting coincidence that the APA-ME deal was announced this morning as well, given the theme in this piece.

Although a couple of deals does not necessarily make a trend, investors should get ready for a wave of M&A in the energy sector. We saw the Exxon Mobil (NYSE:XOM) - XTO Energy (NYSE:XTO) deal a few months ago, the deal between Arena Resources (NYSE:ARD) and SandRidge Energy (NYSE:SD)about a week ago and now the announced transaction between Haliburton (NYSE:HAL) and Boots & Coots (AMEX:WEL).

I believe these are just the first moves in a larger trend. With the credit and equity markets a little closer to normal, rising energy prices and increasing pressures on large energy company executives to "do something," merger and acquisition activity is going to look like an increasingly attractive option to many CEOs

The rest of the story at: 
http://stocks.investopedia.com/stock-analysis/2010/If-You-Cant-Beat-Em-Buy-Em-XOM-XTO-HAL-RIG-UPL0415.aspx 

I Want To Cry ... No, Wait ... I Want To Scream

This morning I wake up a little late, look through the news ... and suddenly feel quite depressed. Apache (APA) has announced that it's buying Mariner Energy (ME) for about $26 a share in stock and cash.

Why do I care?

Because ME was sitting right at the top of my to-buy list ... Hell, I was expecting to place the order later today or early tomorrow.

If there's good news here, it's that APA is paying almost exactly what I think ME is worth. So, I'm not happy to be missing a 50% gainer, but at least I know my methodologies for valuing E&P companies isn't totally off-base (or if it is, at least APA is just as wrong as I am).



Back to the drawing board.

Wednesday, April 14, 2010

Jamie Dimon, You Magnificent Bastard

With JPMorgan reporting earnings this morning, and beating estimates, I'm a happy owner who is once again reminded of the virtues of having top-notch management at the head of the companies they own.

JPM beat bottom-line estimates by $0.10 this morning ($0.74 v. $0.64), and the details in the release were quite sound. Credit provisions were pretty sound, and Dimon was damn-near ebullient when talking about the business and it's near-term prospects. Dimon, like most bankers, is not a guy given to blowing sunshine, so for him to get excited means something to me.

I-banking was really, really strong this period. I don't have a great sense of their marketshare yet, but my sense of it is that they're definitely making some gains.

Retail banking and credit cards were both soft. Is anybody surprised? I thought it was interesting to see the provisioning in both businesses to be roughly equal, even though the banking business is quite a lot bigger. Of course, most people will save their house before they'll save their plastic, so it's not a huge shock.

The one thing I'm not thrilled about was the ROE. I mean, ROE comes down to math and I'm not shocked that this metric didn't pick up, but it's the one issue I'm worried about. As a matter of fact, I would not be surprised to see Dimon over-provisioning the company and seeing a sizable jump in that ROE in a couple year's time. In the meantime, this company is quickly starting to leave some of its would-be competitors in the dust.

I'm a happy owner here and I'll continue to be an owner. And these results should make anybody holding shares of banks like BB&T, USBancorp, Bank of America, et. al feel a lot more comfortable.

Disclosure - I own shares of BBT and JPM

Monday, April 12, 2010

Investors Could Reap Profits From Monsanto

Here's the latest article of mine on Investopedia:
http://stocks.investopedia.com/stock-analysis/2010/Investors-Could-Reap-Profits-From-Monsanto-MON-DD-SYT-POT0412.aspx

One of the classic clichés of the investment world is that "trees don't grow to the sky"; sooner or later, the mightiest of stocks stumbles. Investors who have been around a few years can no doubt recall plenty of examples ranging from Dell to Amgen, to even mighty Microsoft.

Now it is Monsanto's (NYSE:MON) turn.

How Monsanto Lost its Groove
This agribusiness giant has been a stellar performer in the stock market for most of its history, but performance stalled out in 2008 and has not come back since. With Wednesday's earning release, and a significant adjustment both to guidance and the company's operating philosophy, it seems that many of the analysts and professional investors who were not already souring on Monsanto are heading to the sidelines.

The rest can be found at: http://stocks.investopedia.com/stock-analysis/2010/Investors-Could-Reap-Profits-From-Monsanto-MON-DD-SYT-POT0412.aspx

Wednesday, April 7, 2010

And we're back...

After more than a year in sleep mode, I'm bringing this blog back to life.
Not sure what it's going to be ... maybe just a listing of articles I do for Investopedia et.al, or maybe something a little more comprehensive and involved. Time will tell...

Saturday, February 7, 2009

Chinese portfolio torture

It's a true burden of the anal-retentive that we have to feel like we're "on top" of so many things.

Take my portfolio, for instance.

I do well; beating the market several years in a row now (though losing money and "beating" the market is pretty weak tea). And yet, one week of weak performance bums me out.

The ongoing odyssey of visiting companies continues ... and the information isn't all that happy. Healthcare is definitely seeing a slowdown -- hospitals don't want to pony up cash, people are losing jobs (and their insurance) and people are worried about paying co-pays and taking time to recuperate. Even if you add in some folks who rush to get medical care in anticipation of layoffs and losing insurance, the trend is down, down, down....

Tuesday, January 27, 2009

This and that

You know, travel is an odd thing.

On one hand, it's a real p*i*t*a to sleep in someone else's bed, put up with the nickel-and-dime hotel shakedowns, and sit in flying metal tubes with 150 of your new closest friends.

On the other hand, it's really the only way to see what's going on in parts of the country that are not your own. And being out on the West Coast and New England was interesting to me.

Hotels? Well, there are people there ... but they certainly aren't full. The airplanes? They're pretty full. The restaurants? They're pretty empty. I was at a pretty tony eating/shopping area in Glendale (part of the LA megaplex) and it seemed near-vacant. A great sushi place in San Clemente ... I was the only one there. A great Chinese place in Oakland ... almost empty.

But the crappy Chevvy's in Richmond, CA was full. Figure THAT one out!

In the meantime, companies continue to spew out layoffs like a frat boy on a homecoming bender. Things are still going to get worse before they get better.

Oh, and I wonder where the Dow would be if it were a proper market cap-weighted index instead of a ridiculous price-weighted index. It's an odd little quirk of our system that we place so much weight on things that are trivial (P/E's, the Dow, etc.) and so little attention to things that really matter (cash flow, ROIC, credit spreads).

Probably a metaphor there...

Friday, January 9, 2009

End 'o the line

Well, I figured this was coming ... but I won't be able to continue writing for paid external sites (like Investopedia) so long as I'm a sell-side analyst.

As I said, I assumed it would have to be this way ... having a senior analyst writing without direct supervision/review is every compliance officer's worst nightmare.

So, what of this blog? It's all up to you guys, really.

If I hear from you (either email or posts) that you'd like me to continue, I'll try. I'll try to do company-specific analysis (but NOTHING in my coverage industry, nor anything covered by my firm) like I have done for Motley Fool and Investopedia.

If I don't hear from you ... well, I'll probably still use this as a place to scribble random thoughts, but I won't be pretending to do anything on a regular/consistent basis.

So, lemme know!

Wednesday, December 24, 2008

Happy Christmas everyone!

(sorry, I prefer the British version of the greeting!)

I hope you all have a relaxing and enjoyable holiday with your family and friends, however you prefer to spend it.

Me? I'll be watching a non-stop marathon of various versions/editions of Dickens' Christmas Carol. I think I have at least 7 different versions saved on the DVR. What can I say? That's Christmas to me... especially in an area like Durham, North Carolina where it doesn't look quite as Christmas-y as it used to in the upper Midwest where I grew up.

I hope to have more of a "year in review" in the next couple of days, so watch for that.

Once again, Happy Christmas! everyone ...

Tuesday, December 16, 2008

Fed cuts rates; serfs rejoice!

So, the Fed drops rates to almost nothing ... and the markets rejoice!

Ummm... they do know that the Fed is doing this because the underlying economy is really, really weak and we're at serious risk of deflation, right? Right? Now, I'll never turn my nose up at a nice 4-5% one-day rally in the market (particularly after a year like this), but we're not out of the woods by a long stretch.

If the dollar gets weaker (and with rates this low, there's a good chance of that happening before too long), oil and metals get more expensive. And whatever relief we've all been getting from $1.60/gal gasoline all goes "poof!".

There's a curious (and unenviably difficult) conundrum here. I happen to think we ARE (or were) at risk of Japan-style deflation, and a reasonable solution to that is to drop rates. On the other hand, if we get another round of weak-dollar commodity inflation, that means another python-squeeze to the stressed out consumer. And that's bad too.

I'm still waiting for my crystal ball to get back from the shop, so I'm just going to sit tight and keep on doing what I've been doing. Which, in a nutshell, is "prepare for the worst and hope for the best".

Just the FactSet, Ma'am

Well, FactSet (NYSE: FDS) has done it again ... strong revenue and operating income, despite the tough market conditions.

It's interesting to see the subscription numbers; interesting particularly that there hasn't been any apparent impact to all of the hedge funds that are going out of business, nor the spending cutbacks that are going on at bigger institutional shops. So while hedge funds aren't a huge part of FactSet's business (about 6% of subscription value according to this quarter's data), you'd still think there'd be some knock-on effect.

The bottom line is that clients really do see a lot of value in FactSet. Subscriptions generally cost well above $10,000 a year and many firms have multiple subscriptions. That's not a tremendous expense for a shop like T.Rowe Price or Vanguard, but it is more meaningful for smaller shops. It wouldn't surprise me if some firms have made the choice to cut an extra worker or two in order to keep funding the FactSet feeds. Some may see that as heartless, but I think it's a pretty strong affirmation of the perceived value in the product.

This is a company I can love ... the margins are high, the returns on capital are high, the barriers to entry are high, and the growth potential is high. FactSet has a long way to go to catch Bloomberg in terms of the pervasiveness of the product and the features/information offered ... and Bloomberg itself probably still has a ways to go. So, there's plenty of room to grow for a long time to come.

These shares also look pretty cheap ... though so does almost everything these days. This stock probably can't recover until the overall market looks more stable, but this looks like a good one to start accumulating with an eye towards holding it as a long-term core growth position.

Monday, December 15, 2008

Quick note on future commentary

Thought I'd let you all know that there won't be any more Investopedia articles until the new year (if then...).

In the meantime, I'll still be posting thoughts and missives as time and interest allow.

Friday, December 12, 2008

No Bailout ... no real surprise

I have to confess that I'm surprised that so many people seem surprised that the auto bailout failed.

First, you have to remember that the TARP wasn't wildly popular at the time and the logic behind the auto bailout was even more tenuous.

Second, you've got to think that there are some p*ssed off Republican senators looking to settle some scores and show (in a very public fashion) that they're not dead yet, not going away, and not going to rubber-stamp everything the new Congress/Obama administration wants. So, I look at this as a shot across the bow (or, perhaps, into the bow).

Third, and in in line with the first point, look at how the TARP has worked out. Paulson (and Bernanke) went to Congress and said "give us a boatload of money and minimal supervision ... and we're going to use the bulk of the money to buy distressed assets off of bank balance sheets".

In practice, though, we've all seen that the truth is far different -- the TARP has been used as a bank stabilization fund. Now, politicians lie all the time, but they really don't like being lied to (in other words, so long as they're the ones doing the lying, everything is kosher for them). So, I've got to think that a lot of Congressmen are/were thinking "hey, you fooled me once..." and are not inclined to tick off their constituents a second time only to see another BS proposal go south.

So, what do the auto companies do now?

If things are as bad as they say, they go bankrupt. And maybe that's not so bad over the VERY long haul (in the short run, it's bad for all of us).

There have to be rewards for success and consequences for failure, and bankruptcy is arguably the ultimate consequence for corporate failure. IF the afflicted automakers can seize the opportunity (and get strong, forward-thinking management in place), then they can restructure their business and find a cost structure, product line up, and business philosophy that makes sense.

If not ... well, life goes on.

Thursday, December 11, 2008

What to buy? Why not Ginnies?

I think you have to have some serious stones to buy equities in a big way right now ... so what does that leave?

How about various GNMA funds? You can get a decent yield and decent security. Fidelity (FGMNX) and Vanguard (VFIIX) both have solid offerings here.

Corporate bonds are pretty interesting too, but you've got to strap in for some serious pain. Corps have gotten crushed already ... and yet, the defaults aren't that bad yet. Sure, people will say "oh, the prices are already discounting the defaults that are to come", but are they really?

I don't think so ... I think there's another leg down coming when those defaults start popping up. So, I agree that corps are cheap now ... but you've got to have a real threshold for pain to buy now.

At least with Ginnies, what's the downside? If the government backing behind Ginnies goes south, let's be honest -- NONE of us will be worrying about our porfolios. A lot of the short-term Treasuries are yielding bupkis, so what else is there?

Maybe some international govt bonds? UK and Japan and the like ...
Something worth pondering.


(and I'm also interested in commodity-related income-producing assets like MLPs, but that's for another time).

Finally a little good news for Amylin

Amylin (AMLN) hasn't had the best run of late.

There have been safety concerns about the drug Byetta (largely overblown), competition concerns from rival drugs (not-so-overblown), and worries about the timing, efficacy, and competitive profile of the long-acting version of Byetta. Making matters worse, Amylin management hasn't exactly conducted themselves in the most up-front and transparent matter, burying notice of a potentially significant delay in the LAR drug in an 8-K.

I don't like companies that put out press releases to trumpet success, but try to bury setbacks in SEC filings that they hope no one will read.

In any case, word today from Lilly/Amylin/Alkermes suggests that the can use a current ongoing study in place of a separate bioequivalence study. That's good news, as this company clearly needs to get the LAR drug on the market as quickly as possible...

(full disclosure - I'm long Amylin, though some days I wonder why...)

Brain death - FINRA-style

The biggest downside to going back to the sell-side has got to be the series of FINRA exams you have to take.

Series 7, Series 63, Series 86, and Series 87 -- the four horsemen of brain death.

You learn such worthwhile things as "manipulation is illegal" and "government bonds are quoted in 1/32'nds of par". Wow...

I'm often amazed at how much you have to know for some jobs (London taxi driver, for one) and how little you have to know for others, at least in terms of the official licensing/testing requirements.

Oh well, enough ranting. Time to go back to studying!

Tuesday, December 9, 2008

Big Oil + Big 3?

So ... the car companies have no cash and desperately need capital in order to retool, restructure, and keep on going.

The Big Oil companies have oodles of cash, but can't seem to find enough worthwhile projects for their investment dollars.

So... how about the big gasoline producers going in and rescuing the biggest users of their products? They get to put cash to work, they get to look like heroes, and they can ensure that gasoline maintains a permanent role in the personal transportation industry.



Okay... I'm not really serious about this...

... but it's kinda fun to think about.

Saturday, December 6, 2008

Whither (Wither?) the Markets?

Equity investors feel like they've gotten smacked around pretty hard over the last 12 - 18 months. Yet, if you compare the equity markets to the credit markets, the equity markets have done quite a bit better in many respects.

So does this mean that the equity markets have to head even lower?

Here are some reasons to say "yes":

1) The economy is in bad shape ... and getting worse. This week's economic data is only confirmation for what a lot of us have been thinking/seeing/forecasting for some time. And the data is probably going to get worse at least through the first quarter of 2009.

2) Mortgage borrowers are in deep trouble. It doesn't matter where you look ... subprime, work-outs, ARMs, even prime borrowers are seeing distress and rising delinquencies. As unemployment and payroll declines are likely to increase, it's reasonable to assume that defaults and foreclosure have still higher to rise.

3) Credit curtailment. If you want to spend money these days, you're pretty much stuck with spending your own money. Banks are willing to lend to prime customers who want to buy worthwhile assets, but the days of cash-out re-fi's to buy motorcycles and Coach bags are over for the time being.

4) Consumer retrenchment. All of the above suggests that people won't have the cash, the liquidity, or the willingness to hit the stores and keep buying. Ultimately, this spreads out from the retailers into the general economy.

5) Global malaise. Corporate investment (capex) and exports can help for a quarter or two, but it's kinda like trying to lift a tank with children's birthday balloons ... the U.S. is a consumer economy and there just isn't enough lift in the export sector to outweigh the consumer sector.

That's an admittedly grim outlook ... but there's one factor to consider.

This mortgage meltdown was fueled (in part) by people with little-or-no-money-down mortgages. When these mortgages reset to untenably high levels, the borrower really doesn't have a lot of equity on the line. Consequently, leaving the keys on the kitchen table and walking out doesn't represent a major hit to the personal balance sheet (at least in states where there's no recourse beyond the mortgaged property).

So, for these people, maintaining the credit cards is more important than the mortgage. As long as they can revolve their debt, they have "money". And as long as they have money, they can spend.

A lot of people, then, when faced with higher mortgage payments and little or no equity (or negative equity), may be strongly tempted to say "screw it ... I'll go back to an apartment". And in so doing, so long as they have credit cards, they can keep spending.

That's admittedly not a strong argument in support of the market, but it's an early Saturday morning theory on why the equity markets might still be a little more buoyant than you would think they should otherwise be.

Thursday, December 4, 2008

One More Step For MannKind (MNKD, PFE, LLY, NVO)

My latest for Investopedia:

http://community.investopedia.com/news/IA/2008/One-More-Step-For-MannKind-MNKD-PFE-LLY-NVO1204.aspx

Honestly, folks, where else are you going to get Keynesian economic theory and South Park underpants gnomes in the same blog?

ss

Medtronic Sneezes, Investors Feel Sick (MDT, BSX, STJ)

This one is a little old/late (it was published before Thanksgiving), but I forgot to post it up here.

Better late than never!

http://community.investopedia.com/news/IA/2008/Medtronic-Sneezes-Investors-Feel-Sick-MDT-BSX-STJ1124.aspx

The Retail Abattoir -- Blood on the Selling Floor

Yikes.

I figured same-store sales were going to be bad, but this is pretty gruesome.

Target - down 10.4%. Macy's - down 13.3%. Nordstrom - down 15.9%. Kohl's - down 17.5%. Ab & Fitch - down 28%. American Eagle - down 11%.



Unless my memory is faulty, last year wasn't exactly a blow-the-doors-off, we're-in-the-money month to remember for retail. So, this is a really dreadful performance relative to a year-ago number that wasn't all that unbeatable.

Wal-Mart was up pretty good (3.4%), and BJ's was pretty strong as well. I suspect other off-price retailers like Dollar Tree will show some growth as well.

Does any of this surprise me? I guess not ... but I have to confess that saying aloud "oh yeah, retail is going to get hammered" is one thing, but seeing high-teens declines in SSS does give one a moment of pause.


At the bottom line, people HAVE to save more, consume less, and improve their personal balance sheets. Unfortunately, the U.S. economic is a retail consumption-driven economy; exports or corporate cap-ex investment can keep things afloat for a few quarters, but they don't drive the ship.

So here's the paradox -- people need to rebuild their balance sheets, but if consumption tails off too much companies will start firing more workers. Those fired workers will, in turn, spend even less than they would if they were just cutting back.

There's some (small) hope that that small cadre of American savers will come out of their bunkers and take advantage of the opportunity inherent in desparate retailers. I know that I've already spent more this holiday season than in the past five years combined; I needed to replace some higher-ticket items and I saw some unbeatable bargains for things I could use (but maybe didn't strictly "need").

But here's the rub -- if people like me are coming into your store, you've got a big problem ... because I'm cheap and I'm only buying your stuff when you're willing to take a de minimus margin on it. And I'm willing to bet that most of my fellow penny-pinchers and Herculean savers are the same way; if we're buying, it's likely at your loss.

So what do we do? I think free marketeers and Libertarians are going to just have to swallow hard and accept some good ole fashioned Keynesian fiscal stimulus. What's more, the American public is going to have to accept the reality that stimulus today means taxes tomorrow.

I know, I know ... fat chance of people realizing that. The majority of voters want to be lied to -- they want to be told that they can eat the whole cake in one sitting, never exercise, and yet wind up slim, trim, and damn-near immortal.

Consequences? Responsibility? Maturity? Feh! That's un-American danggit, and after all ... ME WANTEE!!!

In the meantime, them GNMA bonds are looking better and better...

Wednesday, December 3, 2008

Auto Bailouts -- Damned if you do, damned if you don't

So, now the auto companies reportedly want even more money from the gum'mint -- now the bailout request is up to $34B. That's a curious strategy ... if at first you don't succeed, come back and ask for more.

Has this worked for anybody? I mean, when you were a kid and unsuccessfully asked your parents for a toy, did you come back and ask for a more expensive toy after you were told "no"?

Still... I'm not sure the economy can afford the estimated 6M+ job losses that would come in short order if the automakers are allowed to fail. So, that puts us all in the terrible position of having to hold our nose and do "something".

Now me, personally, I'd favor simply having the government step up and promise to provide whatver DIP (debtor-in-possession) funding the companies need if/when they go into bankruptcy. BUT ... there are those who say that consumers wouldn't buy from a auto company that had gone bankrupt, since they wouldn't trust that the warranty would be honored.

I guess that's where the comparisons to the airline industry starts to fall apart. It's true that airlines have been in and out of bankruptcy for decades and it doesn't seem to present much of a hurdle to people buying tickets. But here's the thing -- when you buy an airline ticket, your liability is clearly defined and it's short term (you know exactly how much you've spent, probably less than $1,000, and you know exactly how long you're at risk (until your trip is complete)). With a car, though, you're looking at a much larger expenditure and you never really know when you'll need that warranty to come through for you.

Maybe Paulson is going to announce that he's taking TARP money and establishing a new federal warranty guaranty program. After all, it wouldn't be the stupidest thing that man has done yet (more's the pity...).

Here's a final parting thought -- if the U.S. automakers are gasping now, what happens over the next few years as Chinese and Indian automakers start entering the U.S. market? Tata is coming ... Chery is coming ... and they're bringing friends.

Unless the auto companies have serious and far-reaching plans to fundamentally alter the way they do business, and that includes competing with still more low-cost competitors, this is just an inefficient means of assembling money into a nice, big pile and then torching it.

Tuesday, December 2, 2008

Recession Today ... Depression Tomorrow?

So, we finally get word that we're officially in a recession. Gee, what a relief that it's "official", right?

One of the things I find interesting (and maybe ominous) about this is that the start of the recession was dated as December 2007. Given that I think we're going to bottom out in the spring of next year, that suggests we might actually get a technical "depression" -- after all, one of the definitions of depression is 18 months (or more) of recession.

Now, I don't care a whit about labels; labels work well on canned goods, but not so well on economic conditions. But I can't help but wonder what (if any) the impact on consumer confidence will be if newspapers start splashing "Officials: U.S. in Depression" on their headlines.

Don't get me wrong, I think the "blame the media" fad in the U.S. over the past 10 or 15 years is deplorable and idiotic. But it's foolish to think that constant repetition of a message doesn't ultimately lead a high percentage of the listeners toward accepting/believing it. So if people hear the word "depression", maybe they panic and spend even less.

Well, enough on this for now ... good luck to us all.

Monday, December 1, 2008

Memo to JNJ -- WTF?

I've been a Johnson & Johnson shareholder for some time ... but more and more I'm wondering why.

Today JNJ announced that it's paying a little more than $1B for Mentor -- a company known mostly for breast implants and wrinkle treatments. This follows other phenomenally successful JNJ buys like Conor in recent years (tongue firmly in cheek for those who don't know my sarcasm).

Now, is there real growth potential in the aesthetic and reconstructive segments of health care? Sure. Elective cosmetic procedures are going to slow to a trickle during this recession, but I don't care so much about that ... they'll be back eventually and whether that's 2010, 2011, or 2012 isn't all that important to me. What's more, JNJ does have some exposure to that market already and could (arguably) use more products to leverage it existing salesforce there.

But more and more I wonder if JNJ management really has a plan and, if so, whether that plan is worth hanging around for as a shareholder. I'm not universally opposed to growth-by-acquistion in the med-tech space, and companies like Medtronic have shown that it can be a successful strategy. But I am opposed to serial acquirers who add little to the businesses they buy.

There's plenty of interesting cardiology, neurology, and radiology technologies out there, to say nothing of life sciences and diagnostics. These are technologies that serve real diseases, have solid reimbursement, and can be cornerstone growth platforms for a health care company. Instead, JNJ goes the way of fake ta-ta's.

I hope I'm wrong about this and it turns out that JNJ isn't overpaying for a non-strategic asset, but I'm increasingly feeling that it may be time to sell my JNJ shares and move on to the next big idea.

Thursday, November 20, 2008

Some perspective on the credit markets

Most of us spend nearly all of our time following the stock market(s), and barely (if ever) give a thought to the credit markets. Well, I used to work for a buy-side fixed income shop, so I learned the credit markets and intend to keep following them, as I think they can tell you a lot and round out your analysis.

So what's the state of the credit markets?

I talked to a buddy from my old shop today, he told me that early in the morning that one of the CMBX (an index of Commercial Mortgage-Backed Securities (CMBS)) was down 140 basis points. Now, that doesn't seem like a lot, right?

Until you realize that until about 18 montsh ago, 20bp of movement IN A YEAR was considered pretty much normal. So, in an hour or two of trading, the index moved by 7x the normal amount seen in a year.

Wild times, folks...

Friday, November 14, 2008

Apologies (again) for the delay

I apologize again for having no new content this week. The process of transitioning jobs has been a bit more hectic than I'd forecast.

But, I intend to be back soon (early next week, I hope) with more commentary.


Thanks again.
ss

Monday, November 10, 2008

Sorry for the delay, folks

Sorry that there hasn't been another piece on here since Thursday (and likely won't be another one until at least Wednesday).

Been busy navigating the final days at the current job, figuring out my coverage space for the new job, and so on.

And what with these markets leaving us all energized and enthusiastic!!!

But don't worry, will be back soon with more commentary.

ss

Wednesday, November 5, 2008

Manitowoc Flies South For The Winter (MTW, CAT, ITW)

http://community.investopedia.com/news/IA/2008/Manitowoc-Flies-South-For-The-Winter-MTW-CAT-ITW1105.aspx

Banking Stress Spreads To India's ICICI (IBN, HBC, HDB)

http://community.investopedia.com/news/IA/2008/Banking-Stress-Spreads-To-Indias-ICICI-IBN-HBC-HDB1105.aspx

Hospital Spending Fears Expose SonoSite (SONO, ISRG, VAR)

http://community.investopedia.com/news/IA/2008/Hospital-Spending-Fears-Expose-SonoSite-SONO-ISRG-VAR1105.aspx

You Can Beat KD (KFT, K, GIS) (???)

http://community.investopedia.com/news/IA/2008/You-Can-Beat-KD-KFT-K-GIS1105.aspx

Here's my latest piece on Kraft, for Investopedia.

Folks, I have no idea whatsoever what's up with that title. I submitted the piece with a title along the lines of "Kraftwerk", but it got changed -- which is a normal part of the process. I originally was going to go with Crafty Kraft Crafts ... and then decided to change my medication.

I've asked my editor what the heck that title is supposed to mean. I'll let you know if/when I get an answer...

ss

Compass Minerals Still On Course (CMP, ROH)

http://community.investopedia.com/news/IA/2008/Compass-Minerals-Still-On-Course-CMP-ROH1105.aspx

Monday, November 3, 2008

Get Out and VOTE!!!

This is my semi-obligatory public service announcement.

Whomever you support, and for whatever reason(s), get out tomorrow and make your choice.

If you believe, as I do that "the universe is run by the complex interweaving of three elements: energy, matter, and enlightened self-interest," then express that self-interest.

That is all. I now return you to your regularly scheduled reading.

ss